Search Results - "Grouix, B"
-
1
PBI-4050 reduces liver damage and fibrosis in a high-fat diet mouse model of obesity and metabolic syndrome
Published in Journal of hepatology (2017)Get full text
Journal Article -
2
-
3
Oral Treatment with PBI-4425 Decreases Fibrosis in Carbon Tetrachloride (CCL4)-Induced Hepatic Fibrosis Model
Published in Journal of hepatology (2016)Get full text
Journal Article -
4
P72 ORAL TREATMENT WITH PBI-4050, A NOVEL FIRST-IN-CLASS ANTI-FIBROTIC COMPOUND, REDUCES HEPATIC FIBROSIS AND HEPATOCELLULAR CARCINOMA
Published in Journal of hepatology (01-04-2014)Get full text
Journal Article -
5
D29 UNRAVELING THE EXTRACELLULAR MATRIX: Pbi-4050 Reduces Expression Of Fibrosis Biomarkers In The Biomap Saemyof Primary Human Small Airway Epithelial Cells And Lung Myofibroblasts System
Published in American journal of respiratory and critical care medicine (01-01-2017)“…Protein biomarker expression levels relative to vehicle control were determined in cells treated with PBI-4050 (63 to 500 ^M), and biomarkers were designated…”
Get full text
Journal Article -
6
D109 UNDERSTANDING THE MECHANISMS OF ACUTE LUNG INJURY: Plasminogen Reduces Acute Lung Injury In An Acute Pancreatitis Model
Published in American journal of respiratory and critical care medicine (01-01-2017)“…Background: Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) in acute pancreatitis still represents a substantial problem, with a…”
Get full text
Journal Article -
7
D109 UNDERSTANDING THE MECHANISMS OF ACUTE LUNG INJURY: Oral Treatment With Pbi-4050 Reduces Acute Lung Injury In An Acute Pancreatitis Model
Published in American journal of respiratory and critical care medicine (01-01-2017)“…Background: Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) in acute pancreatitis still represents a substantial problem, with a…”
Get full text
Journal Article -
8
C79 ADVANCING UNDERSTANDING OF OBSTRUCTIVE LUNG DISEASE: MEDICATIONS AND MECHANISMS OF DELIVERY: Pbi-4425, A Novel First-In-Class Anti-Inflammatory/anti-Fibrotic Compound, Reduces Pulmonary Emphysema And Cutaneous Hyperplasia In Tight-Skin (fbn-1) Mouse
Published in American journal of respiratory and critical care medicine (01-01-2017)“…Rationale: Tight-skin (TSK) mouse, the experimental model for scleroderma, develops cutaneous hyperplasia, cardiac hypertrophy, pulmonary emphysema and…”
Get full text
Journal Article -
9
C75 FIBROSIS: CURRENT AND FUTURE APPROACHES: Pbi-4425, A Novel First-In-Class Anti-Inflammatory/anti-Fibrotic Compound, Inhibits Collagen I And CTgf Production In Human Fibroblasts, And Reduces Lung Fibrosis In The Bleomycin-Induced Lung Fibrosis Model
Published in American journal of respiratory and critical care medicine (01-01-2017)“…The aim of this study was to investigate the effect of PBI-4425, a first-in-class anti-fibrotic compound, on collagen I expression in TGF-β1-stimulated human…”
Get full text
Journal Article -
10
LBP-006 - PBI-4050, a potential anti-fibrotic drug, improves liver fibrosis in Alström Syndrome, an ultra-rare disease
Published in Journal of hepatology (01-04-2018)Get full text
Journal Article -
11
PBI-4050, a potential anti-fibrotic drug, improves liver fibrosis in Alström Syndrome, an ultra-rare disease
Published in Journal of hepatology (01-04-2018)Get full text
Journal Article -
12
THU-376 - PBI-4050 reduces liver damage and fibrosis in a high-fat diet mouse model of obesity and metabolic syndrome
Published in Journal of hepatology (2017)Get full text
Journal Article -
13
In Vitro and in Vivo Properties of Bicyclic Lactam Inhibitors: A Novel Class of Low Molecular Weight Peptidomimetic Thrombin Inhibitors
Published in Thrombosis research (01-11-2000)“…We have developed potent and selective thrombin inhibitors with a novel non-peptidic structure. A bicyclic lactam was used as the scaffold on which various P1…”
Get full text
Journal Article -
14
-
15
-
16
In Vitro and in Vivo Properties of Bicyclic Lactam Inhibitors
Published in Thrombosis research (01-11-2000)Get full text
Journal Article -
17
Coordinate expression of group II phospholipase A2 and the acute‐phase proteins haptoglobin (HP) and α1‐anti‐chymotrypsin (ACH) by HepG2 cells
Published in Clinical and experimental immunology (01-04-1997)“…The early response to inflammation is characterized by the synthesis of a variety of proteins under cytokine and glucocorticoid control. During episodes of…”
Get full text
Journal Article -
18
Induction of TNF-alpha and proinflammatory secretory phospholipase A2 by intravenous administration of CAMPATH-1H in patients with rheumatoid arthritis
Published in Journal of rheumatology (01-10-1995)“…To test the effect of infusions of CAMPATH-1H on levels of proinflammatory secretory phospholipase A2 (sPLA2) and tumor necrosis factor alpha (TNF-alpha) in…”
Get more information
Journal Article -
19
A61 LUNG FIBROSIS: ANIMAL MODELS II: Pbi-4050, A Novel First-In-Class Anti-Fibrotic Compound, Inhibits CTgf And Collagen I Production In Human Alveolar Epithelial Cells And Fibroblasts, And Reduces Lung Fibrosis In The Bleomycin-Induced Lung Fibrosis Model
Published in American journal of respiratory and critical care medicine (01-01-2014)Get full text
Journal Article -
20